Searched for
SALIX PHARMACEUTICALS INC
Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...- Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsulesThe approved drug is therapeutically equivalent to Salix Pharmaceuticals Inc's reference listed drug (RLD), Apriso extended-release capsule...
- Glenmark Pharma gets USFDA nod for diabetes management drug"Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food & Drug Administration (USFDA) for metformin h...
- Valeant to sell $2.1 billion in assets to pay down debtSkincare is the largest category in the cosmetics industry, accounting for more than one-third of the global market, according to data trac...
- Lupin gets FDA nod to market ulcerative colitis tablets in USThe company has received tentative approval to market its Balasalazide Disodium tablets 1.1 gm from the United States Food and Drug Adminis...
- Lupin looking to enter new product segments, geographies: MD Nilesh GuptaIn order to consolidate its business globally, the Mumbai-based firm has already inked various agreements in the previous fiscal.
- Lupin launches anti-bacterial Zaxine tablets in CanadaZaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with HE, a complication of liver disease (cirrhosis).
- Pharma in 2014: Deals worth billions and fines worth millionsRanbaxy, founded by the family of Malvinder and Shivinder Mohan Singh, was at the centre of most of the developments for major part of the ...
- Continuously evaluating opportunities for tie-ups with large MNCs: Ramesh Swaminathan, Lupin'We do keep talking to various big pharma companies for various kinds of alliance. So potentially I cannot speak about any deal until it ac...
- Glenmark gets $15 mn plant upgradation advance from SalixGlenmark Pharmaceuticals on Tuesday said it has received USD 15 million (over Rs 65 crore) from Salix Pharmaceuticals Inc, USA.
Load More
